EA201000574A1 - Композиция на основе силиконового геля и лекарственное средство для лечения ран с уменьшенной степенью рубцевания - Google Patents

Композиция на основе силиконового геля и лекарственное средство для лечения ран с уменьшенной степенью рубцевания

Info

Publication number
EA201000574A1
EA201000574A1 EA201000574A EA201000574A EA201000574A1 EA 201000574 A1 EA201000574 A1 EA 201000574A1 EA 201000574 A EA201000574 A EA 201000574A EA 201000574 A EA201000574 A EA 201000574A EA 201000574 A1 EA201000574 A1 EA 201000574A1
Authority
EA
Eurasian Patent Office
Prior art keywords
cuttle
ras
medicine
treatment
reduced
Prior art date
Application number
EA201000574A
Other languages
English (en)
Other versions
EA017174B1 (ru
Inventor
Ирвин Палефски
Ни'кита Уилсон
Original Assignee
Меда Аб
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Меда Аб filed Critical Меда Аб
Publication of EA201000574A1 publication Critical patent/EA201000574A1/ru
Publication of EA017174B1 publication Critical patent/EA017174B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0052—Mixtures of macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/225—Mixtures of macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/60—Liquid-swellable gel-forming materials, e.g. super-absorbents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0019—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/0066—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L83/00—Compositions of macromolecular compounds obtained by reactions forming in the main chain of the macromolecule a linkage containing silicon with or without sulfur, nitrogen, oxygen or carbon only; Compositions of derivatives of such polymers
    • C08L83/04—Polysiloxanes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/428—Vitamins, e.g. tocopherol, riboflavin
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G77/00—Macromolecular compounds obtained by reactions forming a linkage containing silicon with or without sulfur, nitrogen, oxygen or carbon in the main chain of the macromolecule
    • C08G77/42—Block-or graft-polymers containing polysiloxane sequences
    • C08G77/46—Block-or graft-polymers containing polysiloxane sequences containing polyether sequences
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G77/00—Macromolecular compounds obtained by reactions forming a linkage containing silicon with or without sulfur, nitrogen, oxygen or carbon in the main chain of the macromolecule
    • C08G77/48—Macromolecular compounds obtained by reactions forming a linkage containing silicon with or without sulfur, nitrogen, oxygen or carbon in the main chain of the macromolecule in which at least two but not all the silicon atoms are connected by linkages other than oxygen atoms
    • C08G77/50—Macromolecular compounds obtained by reactions forming a linkage containing silicon with or without sulfur, nitrogen, oxygen or carbon in the main chain of the macromolecule in which at least two but not all the silicon atoms are connected by linkages other than oxygen atoms by carbon linkages
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G77/00—Macromolecular compounds obtained by reactions forming a linkage containing silicon with or without sulfur, nitrogen, oxygen or carbon in the main chain of the macromolecule
    • C08G77/70—Siloxanes defined by use of the MDTQ nomenclature

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Dispersion Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Cosmetics (AREA)
  • Compositions Of Macromolecular Compounds (AREA)

Abstract

Данное изобретение представляет собой композицию, включающую циклический силоксан, силиконовую окклюзионную жидкость, силиконовый окклюзионный гель и порошок силиконовой смолы. Композицию используют для заживления ран и уменьшения рубцов.
EA201000574A 2007-09-30 2008-09-30 Композиция на основе силиконового геля и лекарственное средство для лечения ран с уменьшенной степенью рубцевания EA017174B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US99716607P 2007-09-30 2007-09-30
PCT/US2008/078340 WO2009046033A2 (en) 2007-09-30 2008-09-30 Silicone gel-based compositions for wound healing and scar reduction

Publications (2)

Publication Number Publication Date
EA201000574A1 true EA201000574A1 (ru) 2010-10-29
EA017174B1 EA017174B1 (ru) 2012-10-30

Family

ID=40336388

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201000574A EA017174B1 (ru) 2007-09-30 2008-09-30 Композиция на основе силиконового геля и лекарственное средство для лечения ран с уменьшенной степенью рубцевания

Country Status (26)

Country Link
US (2) US8563604B2 (ru)
EP (1) EP2211919B1 (ru)
JP (2) JP5449173B2 (ru)
KR (1) KR101521669B1 (ru)
CN (1) CN101854959B (ru)
AT (1) ATE523210T1 (ru)
AU (1) AU2008308849B2 (ru)
BR (1) BRPI0817607A2 (ru)
CA (1) CA2700382A1 (ru)
DK (1) DK2211919T3 (ru)
EA (1) EA017174B1 (ru)
ES (1) ES2372127T3 (ru)
GE (1) GEP20125661B (ru)
HR (1) HRP20110896T1 (ru)
IL (1) IL204002A (ru)
ME (1) ME01258B (ru)
MX (1) MX2010003503A (ru)
PH (1) PH12013502430A1 (ru)
PL (1) PL2211919T3 (ru)
PT (1) PT2211919E (ru)
RS (1) RS52070B (ru)
SI (1) SI2211919T1 (ru)
TW (1) TW200932292A (ru)
UA (1) UA101812C2 (ru)
WO (1) WO2009046033A2 (ru)
ZA (1) ZA201002201B (ru)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001089464A1 (en) * 2000-05-23 2001-11-29 Unilever Plc Deodorant and/or antiperspirant compositions
CN1234426C (zh) * 2001-07-24 2006-01-04 先进生物技术公司 局部用药物制剂
IL152486A0 (en) 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
US20100124539A1 (en) * 2006-10-16 2010-05-20 Hanson Medical, Inc. Cosmetic preparations
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
ES2372127T3 (es) 2007-09-30 2012-01-16 Meda Ab Composiciones de gel a base de silicona para curar heridas y reducir las cicatrices.
US20100322875A1 (en) 2009-06-18 2010-12-23 Advanced Bio-Technologies, Inc. Silicone scar treatment preparation
CA2769625C (en) 2009-07-29 2017-04-11 Foamix Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
US10029013B2 (en) 2009-10-02 2018-07-24 Foamix Pharmaceuticals Ltd. Surfactant-free, water-free formable composition and breakable foams and their uses
BE1019220A3 (nl) 2010-06-30 2012-04-03 Sylphar Huidverzorgingsproduct voor het behandelen van littekens.
US8491941B1 (en) 2011-01-25 2013-07-23 Tec Laboratories, Inc. Rash treatment with scar prevention
US9592243B2 (en) 2011-04-25 2017-03-14 Warsaw Orthopedic, Inc. Medical devices and methods comprising an anabolic agent for treatment of an injury
US9511077B2 (en) 2011-04-25 2016-12-06 Warsaw Orthopedic, Inc. Medical devices and methods comprising an anabolic agent for wound healing
CN102210886A (zh) * 2011-06-08 2011-10-12 湖南恒邦医疗科技有限公司 一种祛疤凝胶组合物及其制备方法
US20130144225A1 (en) * 2011-12-06 2013-06-06 Jessica Rowen Method And Device For Scar Management
US9592241B2 (en) 2011-12-27 2017-03-14 Cmpd Licensing, Llc Silicone-based composition for skin treatment
CN103191459B (zh) * 2013-04-06 2014-08-06 广东泰宝医疗科技股份有限公司 一种复合硅凝胶护创敷料及其制备方法
JPWO2014175444A1 (ja) * 2013-04-26 2017-02-23 千葉県 抗ｎｌｒｒ１抗体
TWI474823B (zh) * 2013-09-25 2015-03-01 Far Eastern New Century Corp 疤痕凝膠的組成物
US9511034B1 (en) 2013-12-09 2016-12-06 Bio-Silicote, Inc. Method for applying a skin treatment
US9226890B1 (en) 2013-12-10 2016-01-05 Englewood Lab, Llc Polysilicone base for scar treatment
DE202015009464U1 (de) 2014-12-04 2017-09-25 Mary Kay Inc. Kosmetikzusammensetzungen
CN104784211A (zh) * 2015-04-10 2015-07-22 浙江省诸暨市珠力神医用品有限公司 一种用于疤痕治疗及皮肤抗衰老的硅凝胶组合物
CN105168045B (zh) * 2015-09-07 2018-07-17 天津嘉氏堂科技有限公司 一种疤痕防晒修复硅凝胶及制备方法
CH712832B1 (de) * 2016-08-24 2020-04-30 Drossapharm Ag Zusammensetzung für die Verwendung als Wundverband.
CA2978573A1 (en) 2016-09-08 2018-03-08 Foamix Pharmaceuticals Ltd. Compositions and methods for treating rosacea and acne
KR101921727B1 (ko) * 2016-12-28 2018-11-23 주식회사 제네웰 실리콘 수지 조성물, 이의 제조방법 및 이를 포함하는 흉터 치료제
US10496949B2 (en) 2017-01-04 2019-12-03 Christopher Zoumalan Compositions and methods for treating cutaneous conditions
US11559622B2 (en) 2017-07-29 2023-01-24 Edward D. Lin Deformation resistant wound therapy apparatus and related methods of use
US10780201B2 (en) 2017-07-29 2020-09-22 Edward D. Lin Control apparatus and related methods for wound therapy delivery
US11712373B2 (en) 2017-07-29 2023-08-01 Edward D. Lin Wound therapy apparatus with scar modulation properties and related methods
US10729826B2 (en) 2017-07-29 2020-08-04 Edward D. Lin Wound cover apparatus and related methods of use
IT201800005140A1 (it) * 2018-05-08 2019-11-08 Giuseppe Leonardo Federico Tessuto per la realizzazione di indumenti e bendaggi di compressione ed indumento contenitivo realizzato con detto tessuto
KR102234063B1 (ko) * 2018-11-28 2021-03-31 주식회사 현대바이오랜드 흉터개선용 피복 필름 형성을 위한 이액형 겔 조성물
AU2020233126A1 (en) * 2019-03-01 2021-09-30 Wasserman Medic AB Novel compositions and use thereof
CN110403839A (zh) * 2019-09-05 2019-11-05 河南汇博医疗股份有限公司 疤痕修复乳霜及其制备方法和应用
US11213473B1 (en) 2020-09-18 2022-01-04 Christopher Zoumalan Skin brightening composition
CN114917402B (zh) * 2022-04-21 2023-08-15 江西省科学院应用化学研究所 单组分光固化型抗菌硅凝胶医用材料及其制备方法和应用
CN115177548A (zh) * 2022-08-03 2022-10-14 克莱丽缇(上海)企业发展有限公司 一种维c组合物及其在护肤品中的应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5741509A (en) * 1996-08-26 1998-04-21 Alvin S. Berlat Silicone wound dressing
GB9922752D0 (en) 1999-09-27 1999-11-24 Smith & Nephew Medical devices and treatment and prophylaxis
JP4236831B2 (ja) * 2001-07-31 2009-03-11 花王株式会社 滑水性を有する化粧料
GB0216427D0 (en) * 2002-07-16 2002-08-21 Advanced Biotechnologies Inter Wound dressing
JP2005029524A (ja) * 2003-07-09 2005-02-03 Harasawa Pharmaceutical Co Ltd シリコーンを主成分とする皮膚外用剤
US20050100568A1 (en) * 2003-11-12 2005-05-12 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Cosmetic compositions and methods for reducing the appearance of pores
ES2372127T3 (es) 2007-09-30 2012-01-16 Meda Ab Composiciones de gel a base de silicona para curar heridas y reducir las cicatrices.

Also Published As

Publication number Publication date
SI2211919T1 (sl) 2012-02-29
PT2211919E (pt) 2011-12-05
UA101812C2 (ru) 2013-05-13
EP2211919B1 (en) 2011-09-07
EP2211919A2 (en) 2010-08-04
US20090143333A1 (en) 2009-06-04
AU2008308849A1 (en) 2009-04-09
WO2009046033A3 (en) 2010-02-25
BRPI0817607A2 (pt) 2014-10-14
CN101854959A (zh) 2010-10-06
ATE523210T1 (de) 2011-09-15
PH12013502430A1 (en) 2015-12-02
US8563604B2 (en) 2013-10-22
CA2700382A1 (en) 2009-04-09
MX2010003503A (es) 2010-04-21
US20140023610A1 (en) 2014-01-23
JP2010540563A (ja) 2010-12-24
EA017174B1 (ru) 2012-10-30
JP2014055170A (ja) 2014-03-27
RS52070B (en) 2012-06-30
GEP20125661B (en) 2012-10-10
WO2009046033A2 (en) 2009-04-09
PL2211919T3 (pl) 2012-02-29
KR101521669B1 (ko) 2015-05-19
KR20100075583A (ko) 2010-07-02
ZA201002201B (en) 2011-01-26
CN101854959B (zh) 2014-03-19
ME01258B (me) 2013-06-20
AU2008308849B2 (en) 2014-04-24
HRP20110896T1 (hr) 2011-12-31
JP5449173B2 (ja) 2014-03-19
US8859618B2 (en) 2014-10-14
ES2372127T3 (es) 2012-01-16
IL204002A (en) 2012-02-29
DK2211919T3 (da) 2011-12-12
TW200932292A (en) 2009-08-01

Similar Documents

Publication Publication Date Title
EA201000574A1 (ru) Композиция на основе силиконового геля и лекарственное средство для лечения ран с уменьшенной степенью рубцевания
CY1122480T1 (el) Μεθυλικη βαρδοξολονη για τη θεραπεια παχυσαρκιας
ATE530932T1 (de) Antimikrobielle medizinische vorrichtungen mit silbernanopartikeln
BR112013029271A2 (pt) cicatrização de tecido
ATE534378T1 (de) Titrierung von tapentadol
EA201691155A1 (ru) Комбинации ингибиторов гистондеацетилазы и иммуномодулирующих лекарственных средств
EA201491009A1 (ru) Гель лизата тромбоцитов
ATE481990T1 (de) Implantierbare medizinprodukte aus verzweigten polymeren
WO2012021786A3 (en) Anti-hemagglutinin antibody compositions and methods of use thereof
EA201170349A1 (ru) Модуляторы mif
DE602008005118D1 (de) Verbesserte synthese kationischer siloxanpräpolymere
DE602006010656D1 (de) Hydrogel für Wundbehandlung
DK2126049T3 (da) Antistoffer mod humant cytomegalovirus (hCMV)
DE602007005697D1 (de) Verwendung von carrageenan zur behandlung von rhinovirus-infektionen
EA201891610A1 (ru) Производные 3-(карбоксиэтил)-8-амино-2-оксо-1,3-диазаспиро[4.5]декана
ATE536368T1 (de) Konjugate von zytotoxischen verbindungen mit peptiden
DE602007013166D1 (de) Einsatz von Agomelatin zur Herstellung von Medikamenten zur Behandlung des Smith-Magenis-Syndroms (SMS)
ATE475424T1 (de) Cellulosesulfat zur behandlung von rhinovirus- infektionen
BR112018075318A2 (pt) poliorganossiloxano reticulado e composição de cuidado pessoal contendo o mesmo
EA201290699A1 (ru) Способы внутреннего контроля или лечения от личинок овода у лошадиных
EA202091062A1 (ru) Карбоксилхитозан
EA200900603A1 (ru) Применение тимозин альфа-1 для получения лекарственного средства для профилактики и лечения аллергических реакций
UA126148U (uk) Спосіб лікування періімплантного мукозиту
EA201170673A1 (ru) Композиция
EA201000045A1 (ru) Антисептическое раневое покрытие